Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SAH-p53-8 |
Synonyms | |
Therapy Description |
SAH-p53-8 is a synthetic peptide stabilized by hydrocarbon crosslinking that preferentially binds MDM-4, disrupting p53-MDM4 binding, thus releasing sequestered p53 protein (PMID: 21075307). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SAH-p53-8 | MDM4 inhibitor 8 | SAH-p53-8 is a synthetic peptide stabilized by hydrocarbon crosslinking that preferentially binds MDM-4, disrupting p53-MDM4 binding, thus releasing sequestered p53 protein (PMID: 21075307). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|